📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. (2023)

First Author: Giannakopoulou E

Attributed to: Understanding cell fate decisions in normal and abnormal haematopoiesis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-023-00642-8

PubMed Identifier: 37783807

Publication URI: http://europepmc.org/abstract/MED/37783807

Type: Journal Article/Review

Volume: 4

Parent Publication: Nature cancer

Issue: 10

ISSN: 2662-1347